Vanguard Group Inc Sensei Biotherapeutics, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 573,844 shares of SNSE stock, worth $418,906. This represents 0.0% of its overall portfolio holdings.
Number of Shares
573,844
Previous 573,651
0.03%
Holding current value
$418,906
Previous $395,000
52.41%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SNSE
# of Institutions
27Shares Held
2.32MCall Options Held
0Put Options Held
0-
Newtyn Management, LLC New York, NY930KShares$679,0670.21% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny211KShares$154,0300.0% of portfolio
-
Geode Capital Management, LLC Boston, MA136KShares$99,5120.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX113KShares$82,4170.0% of portfolio
-
Bank Of America Corp Charlotte, NC90.8KShares$66,2560.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $22.4M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...